NF kappa B decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts

Citation
Ihc. Vos et al., NF kappa B decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts, FASEB J, 14(5), 2000, pp. 815-822
Citations number
34
Categorie Soggetti
Experimental Biology
Journal title
FASEB JOURNAL
ISSN journal
08926638 → ACNP
Volume
14
Issue
5
Year of publication
2000
Pages
815 - 822
Database
ISI
SICI code
0892-6638(200004)14:5<815:NKBDOR>2.0.ZU;2-1
Abstract
Monocyte influx secondary to ischemia-reperfusion conditions the renal allo graft to rejection by presentation of antigens and production of cytokines. Monocyte influx depends on NF kappa B-dependent transcription of genes enc oding adhesion molecules and chemokines, Here we demonstrate that cationic liposomes containing phosphorothioated oligodeoxynucleotides (ODN) with the kappa B binding site serving as competitive binding decoy, can prevent TNF -alpha-induced NF kappa B activity in endothelial cells in vitro, In an all ogenic rat kidney transplantation model (BN to LEW), we show that perfusing the renal allograft with this decoy prior to transplantation abolishes nuc lear NF kappa B activity hi vivo and inhibits VCAM-1 expression in the dono r endothelium (P<0.05), At 24 h postreperfusion, periarterial infiltration of monocytes/macrophages was significantly reduced in decoy ODN-treated all ografts compared to control allografts (3.7 +/- 0.7 vs. 9.2+/-1.2 macrophag es/vessel; P<0.01), At 72 h, there was a reduction of tubulointerstitial ma crophage infiltration in decoy ODN-treated kidneys compared to controls (75 .6+/-13.9 vs. 120.0+/-11.2 macrophages/tubulointerstitial area; P<0.05), In conclusion, perfusion of the renal allograft with NF kappa B decoy ODN pri or to transplantation decreases the initial inflammatory response in a stri ngent, nonimmunosuppressed allogenic transplantation model. Therefore, the NF kappa B decoy approach may be useful to explore the role of endothelium and macrophages in graft rejection and may be developed into a graft-specif ic immunosuppressive strategy allowing reduction of systemic immunosuppress ion on organ transplantation.